How effective is Risperdal Consta for Schizophrenia - Paranoid Type? (a real world drug study)

Summary:

Overall ratings: 3.4/5
Long term ratings: 3.5/5

This is a phase IV clinical study of how effective Risperdal consta (risperidone) is for Schizophrenia - paranoid type and for what kind of people. The study is created by eHealthMe from 5 Risperdal consta users and is updated continuously.

What is Risperdal consta?

Risperdal consta has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 17,116 Risperdal consta users. Check the latest studies of Risperdal consta.

What is Schizophrenia - paranoid type?

Schizophrenia - paranoid type is found to be associated with 4 conditions by eHealthMe. Check the latest studies of Schizophrenia - paranoid type.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Aug, 23, 2026

5 people are studied for taking Risperdal consta in Schizophrenia - paranoid type

Overall effectiveness (number of people):

Does Risperdal consta work for your Schizophrenia - paranoid type (overall)?

Long term (1+ years) effectiveness (number of people):

Does Risperdal consta work for your Schizophrenia - paranoid type (long term)?

Risperdal consta effectiveness for Schizophrenia - paranoid type (number of people):

Overall:
  • not at all: 0
  • somewhat: 1
  • moderate: 1
  • high: 3
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 0
  • high: 3
  • very high: 0

Gender of people who take Risperdal consta for Schizophrenia - paranoid type *:

  • female: 0.0 %
  • male: 100 %

Age of people who take Risperdal consta for Schizophrenia - paranoid type *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 40 %
  • 30-39: 40 %
  • 40-49: 20 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Who find Risperdal Consta more effective for Schizophrenia - Paranoid Type?

Gender of people who take Risperdal consta for Schizophrenia - paranoid type *:

  • female: 0.0 %
  • male: 100 %

Age of people who take Risperdal consta for Schizophrenia - paranoid type *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 33.33 %
  • 30-39: 66.67 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Risperdal consta?

- You can start a phase IV clinical trial to monitor Risperdal consta safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on risperidone (the active ingredients of Risperdal consta) and Risperdal consta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: